Skip to main content

Fidelity — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

257
Companies
$26.1B
Total invested
$166.4M
Avg. check
40
Industries
Health Care 13Biotechnology 11Manufacturing 5Biopharma 5Medical 5Therapeutics 5+34 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97120 of 257
Vera Therapeutics
December 2025

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Biotechnology · South San Francisco$261.0M Post-IPO Equity
Butterfly Network
January 2025

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

Artificial Intelligence (AI) · Burlington$75.6M Post-IPO Equity
Nikola Motor Company
December 2024

Nikola Motor Company manufactures heavy-duty commercial battery-electric vehicles, fuel-cell electric vehicles, and energy solutions.

Automotive · Phoenix$100.0M Post-IPO Equity
Path
December 2021

Path is an SEC registered robo-advisor that automates your crypto portfolio investing

Cryptocurrency · Chicago$35.0M Series A
Kura Oncology
January 2024

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

Biopharma · La Jolla$150.0M Post-IPO Equity
Cleerly
December 2024

Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.

Apps · Denver$106.0M Series C
Kalaris Therapeutics (formerly AlloVir)
December 2025

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

Biotechnology · Houston$50.0M Post-IPO Equity
Amaero International
December 2025

Amaero International is an Australian based company that manufactures large-format complex components in metal.

3D Printing · Notting Hill$22.8M Post-IPO Debt
Tenaya Therapeutics
December 2025

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Biopharma · San Francisco$60.0M Post-IPO Equity
Fulcrum Therapeutics
December 2025

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Biotechnology · Cambridge$175.0M Post-IPO Equity
JUUL
November 2023

JUUL is a manufacturer and distributor of electronic nicotine vaporizers.

B2C · San Francisco$1.3B Venture - Series Unknown
Inscripta
January 2023

Inscripta is a life science technology company that develops digital genome engineering solutions.

Biotechnology · Pleasanton$4.4M Venture - Series Unknown
Nu Ride
November 2022

Nu Ride is a company expanding into insurance distribution and wealth advisory services through acquisitions.

Automotive · New York$170.0M Post-IPO Equity
IperionX
January 2026

IperionX is a leading American titanium metal and critical materials company.

Manufacturing · Charlotte$4.6M Grant
PrognomiQ
January 2026

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

Biopharma · San Mateo$11.9M Venture - Series Unknown
Emalex Biosciences
November 2022

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Biopharma · Chicago$270.0M Series D
Quell Therapeutics
November 2021

Quell Therapeutics is a cell therapy company

Association · London$156.0M Series B
CollegeVine
January 2025

CollegeVine is a platform for deploying AI Agents to replace administrative work throughout the higher education sector.

Artificial Intelligence (AI) · BostonSeries C
Mirador Therapeutics
January 2026

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

Biotechnology · San Diego$250.0M Series B
Nuvalent
November 2025

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

Biotechnology · Cambridge$500.0M Post-IPO Secondary
Astera Labs
November 2022

Astera Labs is a semiconductor company that provides connectivity solutions for intelligent systems.

AI Infrastructure · San Jose$150.0M Series D
Alignment Health
November 2024

Alignment Health provides eldercare services.

Health Care · Orange$321.1M Post-IPO Debt
Arrival
November 2023

Arrival is a developer and manufacturer of zero-emission, public transportation vehicles.

Automotive · London$50.0M Post-IPO Debt
Metsera
November 2024

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

Biopharma · New York$215.0M Series B

Where Fidelity invests

Health Care13
Biotechnology11
Manufacturing5
Biopharma5
Medical5
Therapeutics5

About Fidelity's portfolio

How many companies has Fidelity invested in?

Fidelity has invested in 257 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Fidelity invest in?

Fidelity's top investment sectors include Health Care, Biotechnology, Manufacturing, Biopharma, Medical. The firm invests across 40 different industry categories.

What is Fidelity's largest investment?

Among tracked funding rounds, JUUL received $1.3B in a Venture - Series Unknown round. Fidelity's total known invested capital is $26.1B.

What is the average investment size for Fidelity?

Fidelity's average investment size is $166.4M across its portfolio of 257 companies.

What are Fidelity's most recent investments?

Recent Fidelity portfolio additions include Vera Therapeutics, Butterfly Network, Nikola Motor Company, Path, Kura Oncology. These companies were founded in 2020 or later.

Reach the founders behind these 257 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →